Eli Lilly lifts revenue outlook on weight-loss drug sales, trims profit view on deal charges

Eli Lilly raised its full-year revenue forecast and beat third-quarter earnings expectations on ​Thursday, propelled by surging demand for injectable weight-loss drugs that could…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)